Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Yersinia pestis LcrV protein (also known as V-antigen) is a multifunctional virulence factor and a critical component of the type III secretion system (T3SS) in Yersinia pestis, the bacterium that causes plague[1][2][3][7]. It regulates the translocation of cytotoxic effector proteins (Yops) from the bacterium into host cells, facilitating immune evasion and successful infection[1][3][7]. LcrV also modulates the host immune response and serves as a protective antigen, forming the tip complex of the T3SS needle essential for effector delivery[4][7]. The protein shows sequence conservation among epidemic strains but contains polymorphic regions that can influence structural properties and immune recognition[2][5][6]. It is a target for experimental vaccines and immunotherapies, but antigenic variability represents a challenge for broad efficacy[6].
Blocking Yersinia T3SS effector translocation\nNeutralizing virulence by antibody binding
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Yersinia pestis LcrV protein (LcrV).